Souvick Roy

6PUBLICATIONS
27CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 28, 2026
B cell subsets are associated with durable responses in distinct cancer types after immune checkpoint inhibition.

|Feb 17, 2026
CD47 blockade (ALX301) enhances immunoradiotherapy response in HPV negative head and neck squamous cell carcinoma.

Abdula Monther, Riyam Al-Msari, Robert Saddawi-Konefka

|Aug 21, 2025
HPV E5 Mediates Resistance to Chemotherapy and Radiation by Promoting a Stem Cell-Like Phenotype in Head and Neck Squamous Cell Carcinoma.

Souvick Roy, Sayuri Miyauchi, Riley N Jones

|Feb 13, 2025
Correction: Roy et al. Metformin and ICG-001 Act Synergistically to Abrogate Cancer Stem Cells-Mediated Chemoresistance in Colorectal Cancer by Promoting Apoptosis and Autophagy. Cancers 2022, 14, 1281.

Souvick Roy, Yinghui Zhao, Yate-Ching Yuan

|Mar 26, 2022
A Combined Treatment with Berberine and Andrographis Exhibits Enhanced Anti-Cancer Activity through Suppression of DNA Replication in Colorectal Cancer.

Yinghui Zhao, Souvick Roy, Chuanxin Wang

|Mar 10, 2022
Metformin and ICG-001 Act Synergistically to Abrogate Cancer Stem Cells-Mediated Chemoresistance in Colorectal Cancer by Promoting Apoptosis and Autophagy.

Souvick Roy, Yinghui Zhao, Yate-Ching Yuan

Pageof 1

Frequent Collaborators

3 joint publications

Sayuri Miyauchi

3 joint publications

Riley N Jones

2 joint publications

Yate-Ching Yuan

2 joint publications

Sangwoo Shawn Kim